EQL Pharma
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar! Mellozzan® (melatonin) has been approved in Italy
Italy will be the second greenfield market for Mellozzan, after Germany, where EQL, with the help of Italfarmaco's local expertise and infrastructure, will build the brand and generate prescriptions. The response from doctors and patients in Germany has been very good and the EQL hopes for an equally positive response in Italy.
About Mellozzan®
Mellozzan® contains the sleep hormone melatonin and is indicated for children with ADHD and suffering from sleep difficulties, where so-called sleep hygiene measures have not helped. Mellozzan® is also indicated for the short-term treatment of jet lag in adults.
About Italfarmaco
Italfarmaco SpA is one of the most successful pharmaceutical companies in Italy with a group turnover of almost 1,1 billion euros in 2024 and extensive sales and marketing resources in a number of European countries.
| Datum | 2026-03-25, kl 10:36 |
| Källa | Cision |